Tacrolimus (Prograf) is an immunosuppressive medication that helps prevent organ rejection in kidney transplant patients. It works by decreasing the activity of the immune system to protect the transplanted kidney. This medication is taken orally and needs to be taken consistently at the same time each day.

Mycophenolate mofetil (CellCept) is another immunosuppressive medication used to prevent organ rejection in kidney transplant recipients. It works by reducing the activity of the immune system in a different way than tacrolimus. This medication helps protect the transplanted kidney by preventing the body from attacking it as a foreign object.

Both medications are essential parts of the anti-rejection treatment plan for kidney transplant patients and are often used together to provide comprehensive protection against organ rejection.

End-stage Renal Disease – A condition where the kidneys permanently lose their ability to filter waste from the blood, requiring kidney transplantation. The disease develops gradually as kidney function deteriorates over time. It affects the body’s ability to maintain proper fluid balance, remove waste products, and regulate various essential substances in the blood.

Kidney Transplant Rejection – A condition where the recipient’s immune system recognizes the transplanted kidney as foreign and attempts to attack it. The rejection process can occur immediately after transplantation or develop over time. The immune response can damage the new kidney’s tissues and affect its function.

Chronic Kidney Failure – A progressive condition where kidney function gradually declines over months or years. The kidneys become less efficient at filtering waste products from the blood and maintaining fluid balance. This condition affects various body systems and can lead to the need for kidney transplantation.